Author

Tezcan Güney

Gilead Sciences (United States)ORCID 0000-0002-4587-6773Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alicia Zhang· 1 shared Aman ModiiD· 1 shared Bhavna Malik· 1 shared Daniel K. NomuraiD· 1 shared Emily A. Lau· 1 shared Gregory T. Notte· 1 shared John E. Eksterowicz· 1 shared Kelvin LiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alicia Zhang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Stereoselective Covalent Inhibitor of the Ovarian Cancer-Driving Transcription Factor PAX8

Taylor M Nuttall, Aman Modi, Kelvin Li, Emily A. Lau, Alicia Zhang, Bhavna Malik, Tezcan Güney, John E. Eksterowicz, Gregory T. Notte, Thomas J. Maimone, Daniel K. Nomura

This paper develops a stereoselective covalent inhibitor of PAX8, a key ovarian cancer driver, showing its ability to reduce PAX8 abundance and suppress its transcriptional program.

bioRxiv · Aug 21, 2026 · PreprintBiochemistry